Company Filing History:
1 out of 915 
1 out of 832,843 Years Active: 2021
Title: The Innovative Contributions of Bridget S. Wilson
Introduction
Bridget S. Wilson is a notable inventor based in Albuquerque, NM (US). She has made significant contributions to the field of targeted therapies, particularly through her innovative work on pre-B Cell Receptor (pre-BCR) antagonists. Her research has the potential to impact therapeutic strategies in various medical applications.
Latest Patents
Bridget S. Wilson holds a patent for "Anti-pre-BCR antagonists and methods." This patent describes the identification of pre-BCR antagonists and their use as targeted therapies. The compositions and methods involve a pre-B cell receptor antagonist engineered for expression as a T cell chimeric receptor. In some embodiments, the pre-BCR antagonists can include an anti-pre-BCR antibody, showcasing her innovative approach to medical treatments.
Career Highlights
Throughout her career, Bridget has worked with Unm Rainforest Innovations, where she has contributed to advancing research and development in her field. Her work has been instrumental in exploring new therapeutic avenues and enhancing the understanding of pre-BCR antagonists.
Collaborations
Bridget has collaborated with esteemed colleagues such as Stuart S. Winter and Michael Frank Erasmus. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Bridget S. Wilson's contributions to the field of targeted therapies through her patent on pre-BCR antagonists highlight her role as a pioneering inventor. Her work continues to inspire advancements in medical research and therapeutic strategies.